Description
BPC-157 TB-500 Research Peptide Blend
BPC-157 TB-500 is a combined research peptide formulation containing two distinct synthetic peptide components: BPC-157 and TB-500.
The two peptides have different molecular characteristics and sequences, making the combination relevant to laboratory investigations involving multi-peptide systems, analytical characterization and controlled experimental models.
LV Longevity Peptides presents this product as a research-use material for qualified laboratory and scientific applications.
The product should be evaluated according to its documented specifications, applicable batch information and analytical documentation.
BPC-157 and TB-500: Two Distinct Peptide Components
The BPC-157/TB-500 blend contains two separate peptide entities.
BPC-157
BPC-157 is a synthetic pentadecapeptide consisting of a defined 15-amino-acid sequence.
Reported molecular formula: C₆₂H₉₈N₁₆O₂₂
Reported molecular weight: approximately 1419.54 g/mol
Reported sequence:
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
These chemical details are also reported on the competitor’s current product page.
TB-500
TB-500 is commonly described in commercial research contexts in relation to Thymosin Beta-4 (Tβ4). The full peptide has a substantially larger molecular structure than BPC-157.
Reported molecular formula: C₂₁₂H₃₅₀N₅₆O₇₈S
Reported molecular weight: approximately 4963.44 g/mol
Research Context
The BPC-157/TB-500 combination can be considered a multi-peptide research system, allowing researchers to evaluate two structurally distinct peptide materials within a defined experimental framework.
Potential laboratory research contexts can include:
- analytical characterization
- peptide identity assessment
- stability investigations
- degradation-profile studies
- peptide compatibility research
- controlled biochemical experiments
- cell-based experimental models
- comparative peptide investigations
These descriptions refer to laboratory research contexts only and should not be interpreted as therapeutic indications.
BPC-157/TB-500 Chemical Information
| Property | BPC-157 | TB-500 |
|---|---|---|
| Peptide | BPC-157 | TB-500 / Tβ4-related material |
| Molecular Formula | C₆₂H₉₈N₁₆O₂₂ | C₂₁₂H₃₅₀N₅₆O₇₈S |
| Approx. Molecular Weight | 1419.54 g/mol | 4963.44 g/mol |
| Peptide Class | Synthetic peptide | Synthetic peptide |
| Sequence | See product documentation | See product documentation |
| Research Status | Research use | Research use |
Do not publish a purity percentage, formulation ratio, vial quantity or physical format here until you provide LV’s actual specifications.
That’s important.
The competitor claims ≥99% HPLC-certified purity, lyophilized white powder and specific solubility information.
We should not automatically duplicate those specifications.
FAQS
What is BPC-157/TB-500?
BPC-157/TB-500 is a combined research peptide formulation containing two distinct synthetic peptide components: BPC-157 and TB-500.
What is BPC-157?
BPC-157 is a synthetic pentadecapeptide characterized by a defined 15-amino-acid sequence.
What is TB-500?
TB-500 is a synthetic peptide commonly discussed in relation to Thymosin Beta-4 (Tβ4). The exact material specification should be verified against the product’s analytical documentation.
Why are BPC-157 and TB-500 combined?
A combined formulation provides researchers with a defined multi-peptide system for controlled laboratory investigation and analytical evaluation.
Avoid saying the combination is “more effective” or produces a particular biological outcome unless supported by appropriate evidence.
What research is BPC-157/TB-500 used for?
The blend may be evaluated in controlled laboratory research involving peptide characterization, stability, analytical testing, compatibility and other defined experimental models.
Reviews
There are no reviews yet.